Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Significant association found between coronary artery risk factors and erectile dysfunction

July 20, 2004

Phase II protocol for NX-1207 accepted by FDA

July 19, 2004

Zonagen reports Androxal phase I/II study results

July 19, 2004

Atorvastatin improves erectile function in men with hypercholesterolemia-related ED

July 19, 2004

European marketing authorization for Vesicare for overactive bladder

July 12, 2004

Aminoalcohol derivatives for the treatment of urinary incontinence

July 9, 2004

NexMed and Schering AG sign Alprox-TD agreement

July 8, 2004

BioXell acquires from Roche rights to new indications for BXL-628

July 6, 2004

Vasopressin V2 receptor antagonist effective aquaretic in vivo

July 2, 2004

NX-1207 shows potential as a front-line treatment for BPH in phase I/II trials

July 2, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...